Clinical trials
Recruiting Carcinoma, Renal Cell trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Erasmus Medical Center | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Mark C Burgmans, MD PhD | 1 |
| Merck Sharp & Dohme LLC | 1 |
| PROspective Renal Cancer Cohort Foundation | 1 |
| Radboud University Medical Center | 1 |
| St. Antonius Hospital | 1 |
| dr. Tom van der Hulle | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 8 |
| Kidney Neoplasms | 3 |
| Bone Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Disease | 1 |
| Liver Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.